HLB파나진

046210KOSDAQ의료용품 및 기타 의약 관련제품 제조업

62.0 / 100

Reference Date: 2026-04-13

Financial Score22.0 / 40

News Sentiment15.0 / 25

Momentum15.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Surged 17.6% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

HLB Panajin is a specialized biotech venture company focusing on PNA (Peptide Nucleic Acid)-based bio materials and molecular diagnostics. The company develops and commercializes diverse diagnostic products, including somatic mutation detection, liquid biopsy, and automated diagnostic technologies, leveraging its PNA platform. Its subsidiary, BioSquare, expands into immunoassay technologies, while the company aims to build an AI-based diagnostic platform and develop PNA-based therapeutics for comprehensive healthcare solutions.

Number of Employees

84people

Average Salary

51.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 19.894.0Point

PBR

1.53Industry Average 1.624.0Point

In line with industry avg

ROE

-4.21Industry Average -4.893.5Point

Below industry avg

Debt Ratio

2.48Industry Average 8.888.0Point

Half of industry avg (excellent)

Trend 2023~20252.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲10.9% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼63.3% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -5.8% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 1Neutral 0Negative 0Average Sentiment Score 70

Positive
HLB파나진, 연내 ‘IVDR’ 전 품목 인증 완료... 유럽 시장서 ...
HLB파나진은 연내 유럽의 강화된 체외진단기기 규정인 IVDR 전 품목 인증을 완료하여 유럽 시장에서 경쟁력을 강화할 예정입니다.

Detailed Momentum

52-week position8.0Point

Near 52w high (80%, uptrend)

Current 2,435Won52-week high 2,65052-week low 1,547

1-month return6.0Point

1m +17.63% (strong rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

9 totalPositive 0Neutral 9Negative 0

Neutral정기주주총회결과2026-03-25
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-25
Neutral기업설명회(IR)개최2026-03-25
Neutral기업설명회(IR)개최2026-03-25
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-03-18